WELCOME

NDC	HCPCS	HCPCS Description	NDC Label	Route of Administration
59676-0303-02	J0885	INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS	PROCRIT (VOLUME PACK VIAL) 3000 U/ML	IJ
59676-0304-01	J0885	INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS	PROCRIT (VIAL) 4000 U/ML	IJ
59676-0304-02	J0885	INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS	PROCRIT (VOLUME PACK VIAL) 4000 U/ML	IJ
59676-0310-01	J0885	INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS	PROCRIT (VIAL) 10000 U/ML	IJ
59676-0310-02	J0885	INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS	PROCRIT (VOLUME PACK VIAL) 10000 U/ML	IJ
59676-0312-04	J0885	INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS	PROCRIT (4X2ML,MDV) 10000 U/ML	IJ
59676-0320-04	J0885	INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS	PROCRIT (MULTIDOSE) 20000 U/ML	IJ
59676-0340-01	J0885	INJECTION, EPOETIN ALFA, (FOR NON-ESRD USE), 1000 UNITS	PROCRIT (PF) 40000 U/ML	IJ
59676-0610-01	J9999	NOT OTHERWISE CLASSIFIED, ANTINEOPLASTIC DRUGS	YONDELIS (PF,LYOPHILIZED) 1 MG	IV
59676-0966-01	Q2050	INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWISE SPECIFIED, 10 MG	DOXORUBICIN HCL LIPOSOME 2 MG/1 ML	IV
59676-0966-02	Q2050	INJECTION, DOXORUBICIN HYDROCHLORIDE, LIPOSOMAL, NOT OTHERWISE SPECIFIED, 10 MG	DOXORUBICIN HCL LIPOSOME 2 MG/1 ML	IV
59730-6502-01	J1556	INJECTION, IMMUNE GLOBULIN (BIVIGAM), 500 MG	BIVIGAM (LATEX-FREE) 100 MG/ML	IV

HCPCS Code	Description	Billing Unit	SA Type
A7005	Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable	Each	N
A7006	Administration set, with small volume filter pneumatic nebulizer	Each	N
A7007	Large voume nebulizer, disposable, unfilled, used with aerosol compressor	Each	N
A7008	Large volume nebulizer, disposable, Prefilled, used with aerosol compressor	Each	N